These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 19715978)

  • 1. Sex mismatch in heart transplantation is associated with increased number of severe rejection episodes and shorter long-term survival.
    Welp H; Spieker T; Erren M; Scheld HH; Baba HA; Stypmann J
    Transplant Proc; 2009; 41(6):2579-84. PubMed ID: 19715978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methotrexate or total lymphoid radiation for treatment of persistent or recurrent allograft cellular rejection: a comparative study.
    Ross HJ; Gullestad L; Pak J; Slauson S; Valantine HA; Hunt SA
    J Heart Lung Transplant; 1997 Feb; 16(2):179-89. PubMed ID: 9059929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of survival after repeat heart transplantation. The Registry of the International Society for Heart and Lung Transplantation, and Contributing Investigators.
    Ensley RD; Hunt S; Taylor DO; Renlund DG; Menlove RL; Karwande SV; O'Connell JB; Barr ML; Michler RE; Copeland JG
    J Heart Lung Transplant; 1992; 11(3 Pt 2):S142-58. PubMed ID: 1622993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
    Herzberg GZ; Rossi AF; Courtney M; Gelb BD
    J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morbidity, functional status, and immunosuppressive therapy after heart transplantation: an analysis of the joint International Society for Heart and Lung Transplantation/United Network for Organ Sharing Thoracic Registry.
    Brann WM; Bennett LE; Keck BM; Hosenpud JD
    J Heart Lung Transplant; 1998 Apr; 17(4):374-82. PubMed ID: 9588582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor-recipient sex mismatch portends poor 10-year outcomes in a single-center experience.
    Kittleson MM; Shemin R; Patel JK; Ardehali A; Kawano M; Davis S; Moriguchi JD; Kobashigawa JA
    J Heart Lung Transplant; 2011 Sep; 30(9):1018-22. PubMed ID: 21550824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival, graft atherosclerosis, and rejection incidence in heart transplant recipients treated with statins: 5-year follow-up.
    Stojanovic I; Vrtovec B; Radovancevic B; Radovancevic R; Yazdanbakhsh AP; Thomas CD; Frazier OH
    J Heart Lung Transplant; 2005 Sep; 24(9):1235-8. PubMed ID: 16143239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-organ transplantation: is there a protective effect against acute and chronic rejection?
    Pinderski LJ; Kirklin JK; McGiffin D; Brown R; Naftel DC; Young KR; Smith K; Bourge RC; Tallaj JA; Rayburn BK; Benza R; Zorn G; Leon K; Wille K; Deierhoi M; George JF
    J Heart Lung Transplant; 2005 Nov; 24(11):1828-33. PubMed ID: 16297789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-year survival rates for all consecutive heart-only and lung-only transplants performed in Eurotransplant, 1997-1999.
    Smits JM; Vanhaecke J; Haverich A; de Vries E; Smith M; Rutgrink E; Ramsoebhag A; Hop A; Persijn G; Laufer G
    Clin Transpl; 2003; ():89-100. PubMed ID: 15387100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oversizing of donor hearts: beneficial or detrimental?
    Costanzo-Nordin MR; Liao YL; Grusk BB; O'Sullivan EJ; Cooper RS; Johnson MR; Siebold KM; Sullivan HJ; Heroux AH; Robinson JA
    J Heart Lung Transplant; 1991; 10(5 Pt 1):717-30. PubMed ID: 1958678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with long-term survival following cardiac transplantation.
    Sareyyüpoğlu B; Kirali K; Göksedef D; Rabuş MB; Tuncer A; Erentuğ V; Mansuroğlu D; Yakut C
    Anadolu Kardiyol Derg; 2008 Oct; 8(5):360-6. PubMed ID: 18849228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular dysfunction after heart transplantation: incidence and role of enhanced immunosuppression.
    McNamara D; Di Salvo T; Mathier M; Keck S; Semigran M; Dec GW
    J Heart Lung Transplant; 1996 May; 15(5):506-15. PubMed ID: 8771506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart transplantation in females: the experience in Puerto Rico.
    Banchs HL; González V; González Cancel I; Quintana C; Calderón R; Altieri PI
    Bol Asoc Med P R; 2005; 97(4):248-56. PubMed ID: 16599066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival after heart transplantation is not diminished among recipients with uncomplicated diabetes mellitus: an analysis of the United Network of Organ Sharing database.
    Russo MJ; Chen JM; Hong KN; Stewart AS; Ascheim DD; Argenziano M; Mancini DM; Oz MC; Naka Y;
    Circulation; 2006 Nov; 114(21):2280-7. PubMed ID: 17088463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble CD30 levels in recipients undergoing heart transplantation do not predict post-transplant outcome.
    Ypsilantis E; Key T; Bradley JA; Morgan CH; Tsui S; Parameshwar J; Taylor CJ
    J Heart Lung Transplant; 2009 Nov; 28(11):1206-10. PubMed ID: 19782609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunologic sensitization in recipients of left ventricular assist devices.
    John R; Lietz K; Schuster M; Naka Y; Rao V; Mancini DM; Rose EA; Smith CR; Oz MC; Edwards NM; Itescu S
    J Thorac Cardiovasc Surg; 2003 Mar; 125(3):578-91. PubMed ID: 12658200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of gender on heart transplantation outcomes: a single center experience.
    De Santo LS; Marra C; De Feo M; Amarelli C; Romano G; Cotrufo M
    Ital Heart J; 2002 Jul; 3(7):419-23. PubMed ID: 12189971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoglobulin M-to-immunoglobulin G anti-human leukocyte antigen class II antibody switching in cardiac transplant recipients is associated with an increased risk of cellular rejection and coronary artery disease.
    Lietz K; John R; Burke E; Schuster M; Rogers TB; Suciu-Foca N; Mancini D; Itescu S
    Circulation; 2005 Oct; 112(16):2468-76. PubMed ID: 16230499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytomegalovirus immune globulin (CMVIG) prophylaxis is associated with increased survival after orthotopic liver transplantation. The Boston Center for Liver Transplantation CMVIG Study Group.
    Falagas ME; Snydman DR; Ruthazer R; Griffith J; Werner BG; Freeman R; Rohrer R
    Clin Transplant; 1997 Oct; 11(5 Pt 1):432-7. PubMed ID: 9361936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of heart transplants 15 to 20 years ago: graft survival, post-transplant morbidity, and risk factors for mortality.
    Roussel JC; Baron O; Périgaud C; Bizouarn P; Pattier S; Habash O; Mugniot A; Petit T; Michaud JL; Heymann MF; Treilhaud M; Trochu JN; Gueffet JP; Lamirault G; Duveau D; Despins P
    J Heart Lung Transplant; 2008 May; 27(5):486-93. PubMed ID: 18442713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.